# Evaluation of Satisfaction in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C (Study P04067)

> **NCT00727259** · — · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 1995 (actual)

## Conditions studied

- Hepatitis C, Chronic

## Interventions

- **BIOLOGICAL:** Peginterferon alfa-2b (SCH 54031)
- **DRUG:** Ribavirin (SCH 18908)

## Key facts

- **NCT ID:** NCT00727259
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 1995 (ACTUAL)
- **Last updated:** 2015-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00727259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00727259, "Evaluation of Satisfaction in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C (Study P04067)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00727259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*